US FDA OKs monthly maintenance dosing for Eisai/Biogen's Alzheimer's drug
The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...
I Tried TikTok's "Floor Time" Trend and Now I'm Never Going Back
"Floor time" is trending on TikTok for its therapeutic effects. We tried the free wellness hack and spoke to experts to ...
Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Bio-Techne Corp. stock underperforms Thursday when compared to competitors
This was the stock's second consecutive day of losses.
Scaleready Announces A G-Rex® Grant Has Been Awarded To Brainchild Bio
ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that BrainChild Bio has been awarded a $300,000 G-Rex® Grant. The G-Rex® Grant will ...
Barchart on MSN6d
Bio-Techne Earnings Preview: What to Expect
Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, ...